by andrewmm2007 | Dec 27, 2022 | Press Releases
Judy Ashworth, MD, Chief Medical Officer of Novadip Biosciences SA Mont Saint-Guibert, Belgium – December 27, 2022 – Novadip Biosciences SA (“Novadip” or “the Company”), a clinical stage company developing treatments to regenerate impaired tissue in patients with...
by andrewmm2007 | Dec 20, 2022 | Past Events
Novadip Biosciences will be in San Francisco, California January 9-12, 2023 for JPM Week 2023. Please reach out if you would like to schedule a meeting.
by andrewmm2007 | Dec 9, 2022 | Featured News
Novadip Biosciences – a company developing regenerative tissue products to accelerate large bone defect healing – announced positive data from its phase 1/2 clinical trial.
by andrewmm2007 | Dec 8, 2022 | Featured News
Novadip Biosciences announced positive data from its Phase I/II clinical trial evaluating the safety and clinical activity of its investigational product, NVD-003, in patients with severe bone non-union (BNU) of the lower limb following trauma.
by andrewmm2007 | Dec 8, 2022 | Featured News
Novadip Biosciences SA has announced positive data from its phase 1/2 clinical trial evaluating the safety and clinical activity of its investigational product, NVD-003.
